Neurocrine Biosciences
NBIX
#1203
Rank
โ‚น1.331 T
Marketcap
โ‚น13,155
Share price
-0.96%
Change (1 day)
11.36%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): โ‚น54.78 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are โ‚น2.24 Billion. In 2023 the company made an earning of โ‚น31.18 Billion, an increase over its 2022 earnings that were of โ‚น19.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น54.78 B75.7%
2023 โ‚น31.18 B62.85%
2022 โ‚น19.14 B73.74%
2021 โ‚น11.02 B-8.82%
2020 โ‚น12.08 B77.78%
2019 โ‚น6.79 B49.83%
2018 โ‚น4.53 B-142.57%
2017 -โ‚น10.66 Billion-14.73%
2016 -โ‚น12.51 Billion53.15%
2015 -โ‚น8.17 Billion46.25%
2014 -โ‚น5.59 Billion29.66%
2013 -โ‚น4.31 Billion-3530.8%
2012 โ‚น0.12 B-95.73%
2011 โ‚น2.93 B
2009 -โ‚น4.14 Billion-45.38%
2008 -โ‚น7.57 Billion-58.87%
2007 -โ‚น18.4 Billion87.3%
2006 -โ‚น9.82 Billion351.97%
2005 -โ‚น2.18 Billion-52.09%
2004 -โ‚น4.54 Billion-10.98%
2003 -โ‚น5.1 Billion
2001 -โ‚น3.81 Billion
1999 -โ‚น1.72 Billion108.32%
1998 -โ‚น0.83 Billion
1996 โ‚น0.25 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น1.66 B-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น166.45 B 192.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น2.81 Billion-104.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น879.51 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น623.59 B 995.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น601.59 B 957.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.66 Billion-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น3.62 Billion-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA